Genetic Testing Should Be Component Of Diagnostic Evaluations For Adult Patients With Epilepsy, Research Suggests

Healio (12/3, Herpen) reports “genetic testing, which is likely to identify underlying genetic causes for the condition, should be a component of diagnostic evaluations for adult patients with epilepsy, according to new research.” The study found 36.4% of “patients’ genetic tests yielded pathogenic variants related to epilepsy, with the most common variants being mutations in TSC2 (15.4%), SCN1A (8.8%), TBC1D24, and TSC1 (4.4% each).” The findings were presented at the American Epilepsy Society annual meeting.